Patient perceptions of discomfort and changes in vision and functional status associated with intravitreal triamcinolone injection

Am J Ophthalmol. 2006 Sep;142(3):492-4. doi: 10.1016/j.ajo.2006.03.042.

Abstract

Purpose: To assess patient perceptions concerning discomfort and changes in vision associated with intravitreal triamcinolone injections (IVTA).

Design: Prospective consecutive case series.

Methods: Fifty patients treated with IVTA between June 2003 and February 2005 were interviewed by telephone 10 to 12 weeks after injection. Each question was answered on a 1 to 5 scale.

Results: There was no significant difference in reported amount of ocular discomfort pre-injection vs post-injection (1.0 vs 1.1, respectively). Expected pain level (2.9) was higher than the actual pain level (1.6; P < .001). Patients' self-reported vision improved from 2.7 to 3.7 (P < .001). Thirty (60%) patients reported improved vision and 20 (40%) reported no change. Thirty-three (66%) patients reported more visual improvement than expected.

Conclusions: Patient expectation of discomfort during IVTA was greater than their actual experience; approximately two-thirds of patients reported improved vision and about one-third reported improved functional status after injection.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Glucocorticoids / administration & dosage*
  • Humans
  • Injections
  • Male
  • Middle Aged
  • Pain Measurement
  • Patient Satisfaction*
  • Patients / psychology*
  • Prospective Studies
  • Retinal Diseases / drug therapy
  • Triamcinolone Acetonide / administration & dosage*
  • Vision, Ocular / physiology*
  • Vitreous Body

Substances

  • Glucocorticoids
  • Triamcinolone Acetonide